SAADH MJ. SARS-COV-2 3CL-PROTEASE INHIBITORS AS ANTIVIRAL AGENT AGAINST COVID-19. Int J App Pharm [Internet]. 2022 Nov. 7 [cited 2025 Dec. 5];14(6):18-20. Available from: https://www.journals.innovareacademics.in/index.php/ijap/article/view/46015